Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases

Neurochemical Research

Volumn 32, Issue 6, 2007, Pages 1046-1055

  Cognato, Giana De Paula ^a   Bruno, Alessandra Nejar ^a   Da Silva, Rosane Souza ^b   Bogo, Maurício Reis ^b   Sarkis, João José Freitas ^a   Bonan, Carla Denise ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adenosine; Antiepileptic drugs; Ecto 5 nucleotidase; Epilepsy; NTPDases

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ECTO 5' NUCLEOTIDASE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; PHENYTOIN; PILOCARPINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; ENZYME ANALYSIS; EPILEPSY; HIPPOCAMPUS; HYDROLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; CEREBRAL CORTEX; EPILEPSY; HIPPOCAMPUS; MALE; MUSCARINIC AGONISTS; PHENYTOIN; PILOCARPINE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNAPTOSOMES; VALPROIC ACID;

RATTUS;

EID: 34248164936     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9272-y     Document Type: Article

References (52)

1. Majores M, Eils J, Wiestler OD et al (2004) Molecular profiling of temporal lobe epilepsy: Comparison of data from human tissue samples and animal models. Epilepsy Res 60:173-178
2. Shorvon SD (1990) Epidemiologia, classificação, história natural e genética da epilepsia. In: Costa JC (ed) Epilepsy a lancet review. The Lancet, London, pp 3-13
3. Cavalheiro EA, Leite JP, Bortolotto ZA et al (1991) Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32:778-782
4. Mello LE, Cavalheiro EA, Tan AM et al (1993) Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34:985-995
5. Cavalheiro EA (1995) The pilocarpine model of epilepsy. Ital J Neurol Sci 16:33-37
6. Leite JP, Garcia-Cairasco N, Cavalheiro EA (2002) New insights from the use of pilocarpine and kainite models. Epilepsy Res 50:93-103
7. Loscher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342:1-13
8. Ragsdale DS, Avoli M (1998) Sodium channels as molecular targets for antiepileptic drugs. Brain Res Brain Res Rev 26:16-28
9. Borowicz KK, Luszczki J, Czuczwar SJ (2002) 2-Chloroadenosine, a preferential agonist of adenosine A1 receptors, enhances the anticonvulsant activity of carbamazepine and clonazepam in mice. Eur Neuropsychopharmacol 12:173-179
10. Assi AA (2001) N6-cyclohexyladenosine and 3-(2-carboxy-piperazine-4-yl)- 1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice. J Pharm Pharm Sci 4:42-51
11. Phillis JW (1984) Interactions of the anticonvulsants diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia 25:765-772
12. Weir RL, Padgett W, Daly JW et al (1984) Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system. Epilepsia 25:492-498
13. Van Calker D, Steber R, Klotz KN et al (1991) Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur J Pharmacol 206:285-290
14. Biber K, Walden J, Gebicke-Harter P et al (1996) Carbamazepine inhibits the potentiation by adenosine analogues of agonist induced inositolphosphate formation in hippocampal astrocyte cultures. Biol Psychiatry 40:563-567
15. Ribeiro JA, Sebastião AM, Mendonça A (2003). Participation of adenosine receptors in neuroprotection. Drug News Perspect 16:80-86
16. Dragunow M (1988) Purinergic mechanisms in epilepsy. Prog Neurobiol 31:85-108
17. During MJ, Spencer DD (1992) Adenosine: a mediator of seizure arrest and postictal refractoriness. Ann Neurol 32:618-624
18. Brundege JM, Dunwiddie TV (1997) Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv Pharmacol 39:353-391
19. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55
20. Robson SC, Sévigny J, Zimmermann H (2006) The ENTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2:409-430
21. Zimmermann H (1996) Biochemistry, localization and funtional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 49:589-618
22. Cunha RA (2001) Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem Res 26:979-991
23. Burnstock G (2004) Cotransmission. Curr Opin Pharmacol 4:47-52
24. Marcinkiewicz M, Nagao T, Day R et al (1997) Pilocarpine-induced seizures are accompanied by a transient elevation in the messenger RNA expression of the prohormone convertase PC1 in rat hippocampus: comparison with nerve growth factor and brain-derived neurotrophic factor expression. Neuroscience 76:425-439
25. Esclapez M, Houser CR (1999) Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. J Comp Neurol 412:488-505
26. Weise J, Engelhorn T, Dorfler A et al (2005) Expression time course and spatial distribution of activated caspase-3 after experimental status epilepticus: contribution of delayed neuronal cell death to seizure-induced neuronal injury. Neurobiol Dis 18:582-590
27. Bonan CD, Walz R, Pereira GS et al (2000) Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy. Epilepsy Res 39:229-238
28. Bonan CD, Amaral OB, Rockenbach IC et al (2000) Altered ATP hydrolysis induced by pentylenetetrazol kindling in rat brain synaptosomes. Neurochem Res 25:775-779
29. Turski WA, Cavalheiro EA, Coimbra C et al (1987) Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res 434:281-305
30. Luchowska E, Luchowski P, Wielosz M et al (2002) Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock. Pharmacol Biochem Behav 71:223-231
31. Nagy A, Delgado-Escueta AV (1984) Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient (Percoll). J Neurochem 43:1114-1123
32. Battastini AM, Da Rocha JB, Barcellos CK (1991) Characterization of an ATP diphosphohydrolase (EC 3.6.1.5) in synaptosomes from cerebral cortex of adult rats. Neurochem Res 16:1303-1310
33. 2+-stimulated ATPase activity. Anal Biochem 157:375-380
34. Heymann D, Reddington M, Kreutzberg GW (1984) Subcellular localization of 5′-nucleotidase in rat brain. J Neurochem 43:971-978
35. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
36. Bigonnesse F, Levesque SA, Kukulski F et al (2004). Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43:5511-5519
37. de Paula Cognato G, Bruno AN, Vuaden FC et al (2005) Ontogenetic profile of ectonucleotidase activities from brain synaptosomes of pilocarpine-treated rats. Int J Dev Neurosci 23:703-709
38. Priel MR, Dos Santos NF, Cavalheiro EA (1996) Developmental aspects of the pilocarpine model of epilepsy. Epilepsy Res 26:115-121
39. Liu Z, Holmes GL (1997) Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits. Neuroscience 76:1129-1138
40. Capella HM, Lemos T (2002) Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpine model of epilepsy. Epilepsia 43:110-111
41. Phillis JW, Wu PH (1982) The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol C 72:179-187
42. Horvat A, Orlic T, Banjac A et al (2006) Inhibition of rat brain ecto-atpase activity by various drugs. Gen Physiol Biophys 25:91-105
43. Daval JL, Deckert J, Weiss SR et al (1989). Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study. Epilepsia 30:26-33
44. Young D, Dragunow M (1994) Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 58:245-261
45. Angelatou F, Pagonopoulou O, Kostopoulos G (1990) Alterations of A1 adenosine receptors in different mouse brain areas after pentylenetetrazol- induced seizures, but not in epileptic mutant mouse "tottering". Brain Res 554:251-256
46. 1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur J Neurosci 18:820-828
47. 2A receptors in the rat cerebral cortex. Epilepsia 46:159-165
48. Owens MJ, Nemeroff CB (2003) Pharmacology of valproate. Psychopharmacol Bull 37:17-24
49. Leite JP, Cavalheiro EA (1995) Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 20:93-104
50. Das SJ, Olsen I (2001) Up-regulation of keratinocyte growth factor and receptor: a possible mechanism of action of phenytoin in wound healing. Biochem Biophys Res Commun 282:875-881
51. Beutler AS, Li S, Nicol R et al (2005) Carbamazepine is an inhibitor of histone deacetylases. Life Sci 76:3107-3115
52. Tang FR, Lee WL, Gao H (2004) Expression of different isoforms of protein kinase C in the rat hippocampus after pilocarpine-induced status epilepticus with special reference to CA1 area and the dentate gyrus. Hippocampus 14:87-98